FDA authorizes blood plasma treatment for COVID-19 despite questions
The FDA has authorized the emergency use of blood plasma for treatment of COVID-19. 70,000 patients in the U.S. have already received the therapy despite scientists warning the effectiveness is still not clear. Dr. Ron Elfenbein joins CBSN to discuss the move.